Preembryonic diagnosis for sickle cell disease.

Area of Science:

• Reproductive Medicine
• Medical Genetics

Background:

• Preimplantation genetic diagnosis (PGD) traditionally involves embryo biopsy and potential discard of affected embryos, raising ethical concerns.
• Couples at risk for genetic disorders face difficult decisions regarding embryo viability and disposal.

Observation:

• A novel preembryonic genetic diagnosis technique was developed, involving sequential first and second polar body removal and pronuclear-stage oocyte cryopreservation.
• This method was applied to a patient at risk for sickle cell disease, utilizing PCR analysis of polar bodies for maternal allele detection.

Findings:

• Six mutation-free oocytes were identified and successfully used in two clinical cycles, resulting in two pregnancies and one healthy birth.
• Oocytes predicted to carry the abnormal beta-globin gene were not cultured, thereby preventing the formation and subsequent discard of affected embryos.

Implications:

• This approach demonstrates the feasibility of preembryonic diagnosis for single-gene disorders, providing an ethically sound alternative to traditional PGD.
• The technique circumvents the ethical dilemma associated with embryo destruction, offering hope for affected families.